Changes in Operation Profits in Korea's E-cigarette Market

Apr.12.2023
Changes in Operation Profits in Korea's E-cigarette Market
South Korean e-cigarette market sees changes in profits for major participants, with PMI rebounding and KT&G leading with 84% share.

On April 11th, according to a report by South Korean media outlet Bizwatch, there have been some new developments in the profit margins of major players in the country's electronic cigarette market. PhiMo International Korea saw a 163% increase in operating profit in 2022, while BAT Korea's operating profit decreased by 12%. KT&G has a profit margin of 30% and holds a market share of 84%, making it the top player in the South Korean market.


PMI's operating profit rebounds against market trends.


In 2022, there will be changes in the revenue of KT&G, PMI Korea, and BAT Korea.


KT&G and PMI Korea are the top two players in the South Korean electronic cigarette market, while BAT Korea is facing a growth standstill.


Analysts of the South Korean tobacco industry believe that the future profit lies in the electronic cigarette market as the tobacco industry shifts from traditional cigarettes to electronic ones.


According to industry insiders, in 2022, PMI's South Korean company's sales reached KRW 686.8 billion, representing a 21.5% increase compared to 2021. Operating profit increased by 162.5%, reaching KRW 80.6 billion. The operating profit margin increased from 5.4% in 2021 to 11.7% in 2022.


In 2022, KT&G's revenue was 36.94 trillion Korean won, representing a 5.8% increase from 2021. During this period, operating profit grew by 3.4% to reach 11.23 trillion Korean won, resulting in an operating profit margin of 30.3%.


KT&G's overseas tobacco exports and e-cigarette sales drove the growth, as demand for the domestic tobacco market decreased by 1% in 2022. KT&G's overseas cigarette sales in 2022 amounted to KRW 1.98 trillion, a 47.2% increase from 2021. Additionally, the sales of the company's next-generation product (NGP), with 2022 sales totaling KRW 87.63 billion, grew by 73.9%.


BAT Korea reported a 14.3% increase in revenue for 2022, reaching KRW 539.8 billion. However, the company's operating profit decreased by 12% to KRW 44.6 billion, resulting in a decline in operating profit margin from 10.7% in 2021 to 8.3% in 2022. Additionally, the net profit for 2022 decreased by 33.6%, reaching KRW 28.5 billion.


The market share of electronic cigarettes continues to grow.


Although cigarettes still dominate the South Korean tobacco market with a market share of approximately 85%, electronic cigarettes are rapidly replacing traditional cigarettes and are becoming the driving force behind the future profits of tobacco companies.


According to the "2022 Tobacco Market Trends" report released by the South Korean Ministry of Strategy and Finance, the market share of electronic cigarettes in the domestic tobacco market has been steadily increasing since 2017, rising from 2.2% to 9.6% in 2018, 10.5% in 2019, 10.6% in 2020, 12.4% in 2021, and 14.8% in 2022. After a period of stagnation in 2019 and 2020, the market share has been on the rise since 2021.


Changes in Market Share of E-cigarettes | Image Source: 2FIRSTS


In 2022, KT&G held a market share of 47.5% in convenience stores. Additionally, KT&G's electronic cigarette equipment made up 84% of the market share in the same year.


PMI's South Korean company has been actively targeting the electronic cigarette market, launching a new lineup called "IQOS Illuma One" in February 2023 after introducing iCos Illuma in October 2022.


Although KT&G and PMI compete in the domestic market, they have formed an alliance overseas. In January 2023, KT&G signed a 15-year agreement to provide PMI with smoke-free products in the international market (excluding South Korea). In exchange for marketing, distribution, and sales rights of KT&G e-cigarettes overseas, PMI guarantees a minimum distribution of cigarette units to ensure KT&G's profitability.


On the other hand, as reported, BAT has a market share of approximately 10% in the South Korean e-cigarette market. The company recently launched 'Glo HyperX2' in Korea with the goal of rebounding, but there hasn't been a significant shift in market share yet.


According to a Korean industry insider, "After a period of stagnation, the domestic e-cigarette market has slowly grown since 2022, and the challenge is how to further develop the market.


Related reading:


PMI's South Korean outsourcing factory has invested KRW 300 billion for the production of HNB devices.


Demand for heated tobacco in South Korea is expected to surge by 21% in 2022, while cigarette demand is set to decline by 1.8%.


References:


Last year's cigarette sales report shows that BAT Korea failed to meet its targets.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Product | JT Expands Vote-Winning EVO Cacao Mint Crystal to Nationwide Retail in Japan, Adds 22-Stick Limited Pack at Same Price
Product | JT Expands Vote-Winning EVO Cacao Mint Crystal to Nationwide Retail in Japan, Adds 22-Stick Limited Pack at Same Price
Japan Tobacco (JT) will expand EVO Cacao Mint Crystal from limited channels to nationwide retail in Japan from October 6, 2026. The Ploom tobacco stick ranked first in the brand's first consumer voting campaign for new tobacco-stick SKUs held earlier this year. JT will also introduce a limited 22-stick pack at the same JPY 620 price as the standard 20-stick pack. The capsule-format product combines menthol with sweet, bittersweet cacao notes and adds a berry nuance when the capsule is crushed.
Sep.09
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27